To evaluate the prevalence, clinical characteristics, and temporal relationships of autoimmune diseases in children and adolescents with type 1 diabetes mellitus (T1D), and to identify factors associated with their occurrence.
Approach:
Study Design: Retrospective study including 639 children and adolescents with T1D followed at a tertiary pediatric endocrinology center from January 2004 to October 2018.
Data Collection: Demographic, clinical, laboratory, and autoantibody data were reviewed; autoimmune diseases identified through routine screening and clinical follow-up.
Statistical Analysis: Multivariable logistic regression was used to assess factors associated with additional autoimmune diseases.
Key Findings:
18.8% of subjects with T1D had at least one additional autoimmune disease.
Most frequent comorbidities were autoimmune thyroiditis (AIT, 12.7%) and celiac disease (CD, 5.9%), followed by vitiligo (1.3%), autoimmune gastritis/pernicious anemia (0.15%), and autoimmune hepatitis (0.15%).
Female sex was independently associated with the presence of additional autoimmune diseases (OR = 1.61).
Most autoimmune diseases were diagnosed concurrently with or after T1D onset, clustering within the first two years.
Interpretation:
Age at diagnosis of T1D was positively correlated with the age at diagnosis of AIT and CD, indicating a shorter interval between T1D onset and these autoimmune diseases in older patients.
Limitations:
The study was retrospective and relied on medical records, which may have incomplete data.
Not all autoimmune comorbidities, including Addison’s disease, autoimmune gastritis/pernicious anemia, autoimmune hepatitis, and vitiligo, were systematically screened annually.
Conclusion:
Autoimmune comorbidities, particularly AIT and CD, are common in pediatric T1D, with most diagnoses occurring within the first two years around diabetes onset.
Researchers found larger biological age gaps in more recent birth cohorts and observed associations with higher risk of several cancers diagnosed before age 55.